Literature DB >> 9459400

Cutaneous lesions in patients with visceral leishmaniasis and HIV infection.

C Postigo1, R Llamas, C Zarco, R Rubio, F Pulido, J R Costa, L Iglesias.   

Abstract

Cutaneous lesions attributed to Leishmania are very seldom observed in classic Kala-Azar, but recently some reports have mentioned them in patients with HIV infection. We found cutaneous lesions whose biopsy disclosed the presence of Leishmania organisms in six patients of a group of 32 HIV patients with visceral Leishmaniasis. These lesions did not present a uniform or specific appearance, even though they tended to localize symmetrically on acral zones. They consisted of erythematous papules and hypopigmented macules on the dorsa of the hands, feet, and elbows; small subcutaneous nodules on the thighs; and erythematoviolaceous, scaly plaques on the face. These lesions accompanied in every case the other symptoms and/or signs of visceral leishmaniasis, responded to anti-leishmanial treatment, and were sometimes the first indicator of recurrence. The histopathological study was non-specific, but showed in every case the presence of abundant amastigotes within the dermal histiocytes and free in the dermis or subcutaneous tissue. Data from literature review are similar to ours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9459400     DOI: 10.1016/s0163-4453(97)93080-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Cutaneous and visceral leishmaniasis during anti-TNFα therapy.

Authors:  Claudio Guarneri; Valentina Bevelacqua; James W Patterson; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-11-10

Review 3.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis.

Authors:  Washington L C dos-Santos; John David; Roberto Badaró; Luiz A R de-Freitas
Journal:  Parasitol Res       Date:  2003-11-11       Impact factor: 2.289

Review 5.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 6.  Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Authors:  Begoña Monge-Maillo; Francesca F Norman; Israel Cruz; Jorge Alvar; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

7.  Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.

Authors:  Gilles Darcis; Gert Van der Auwera; Jean-Baptiste Giot; Marie-Pierre Hayette; Françoise Tassin; Jorge Arrese Estrada; Lieselotte Cnops; Michel Moutschen; Laurence de Leval; Philippe Leonard
Journal:  BMC Infect Dis       Date:  2017-07-07       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.